Circulating tumor cells and host immunity: A tricky liaison.
Circulating tumor cells
Immune system
Macrophages
Natural killer (NK) cells
Neutrophils
Platelets
Regulatory T cells
T lymphocytes
Journal
International review of cell and molecular biology
ISSN: 1937-6448
Titre abrégé: Int Rev Cell Mol Biol
Pays: Netherlands
ID NLM: 101475846
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
25
9
2023
pubmed:
23
9
2023
entrez:
22
9
2023
Statut:
ppublish
Résumé
During their dissemination, circulating tumor cells (CTCs) steadily face the immune system, which is a key player in the whole metastatic cascade, from intravasation to the CTC colonization of distant sites. In this chapter, we will go through the description of immune cells involved in this controversial dialogue encompassing both the anti-tumor activity and the tumor-promoting and immunosuppressive function mediated by several circulating immune effectors as natural killer (NK) cells, CD4
Identifiants
pubmed: 37739482
pii: S1937-6448(23)00116-8
doi: 10.1016/bs.ircmb.2023.07.002
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-157Informations de copyright
Copyright © 2023. Published by Elsevier Inc.